Curis, Inc. to Present at the Barclays Capital Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Barclays Capital Global Healthcare Conference, at 3:15 p.m. EDT on March 11, 2009, at the Loews Hotel in Miami, Florida.

Back to news